Actively Recruiting
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
Led by Beni-Suef University · Updated on 2026-01-30
300
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to investigate the effects of DPP-4 Is+ metformin versus SGLT2 Is + metformin on the risk of cognitive decline and depression in patients with T2DM.
CONDITIONS
Official Title
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults with Type 2 Diabetes Mellitus aged over 55 years
- Patients must have been taking SGLT2 inhibitors plus metformin or DPP-4 inhibitors plus metformin for at least 1 year
You will not qualify if you...
- Type 1 diabetes or ketoacidosis
- Receiving insulin therapy
- End organ failure such as chronic renal failure, liver failure, or heart failure
- Previous history of pancreatitis
- History of Alzheimer's disease or any brain injury
- Pregnant or breastfeeding females
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beni Suef Hospital
Banī Suwayf, Egypt
Actively Recruiting
Research Team
A
Asmaa Abdelfattah
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here